There was no significant difference in treatment failures between placebo ( 3/35 , 9 % ; 95 % CI , 3-22 ) and active ( 2/39 , 5 % ; 95 % CI , 1-17 ) groups ( relative risk , 0.60 ; 95 % CI , 0.11-3 .37 ) .